PharmaVigilant Introduces I-Builder 2.0
PharmaVigilant has introduced I-Builder 2.0, a study-building solution that is expected to ease the study build process and technology transfer for sponsors. I-Builder can support multiple users for
Rocket Pharmaceuticals has entered into a credit facility agreement of up to $150m with Hercules Capital to support the ongoing development of its cardiovascular portfolio.
FirstCare Health Plans has selected all-in-one IP communications software suite from Interactive Intelligence. The software suite, customer interaction center (CIC), has given FirstCare the ability to support multichannel
Roche’s Stage, a Phase III trial evaluating Ocrelizumab as a treatment for seropositive rheumatoid arthritis (RA) patients with a previous inadequate response to methotrexate (MTX), met its primary